カテゴリー： Allied Market Research, 世界, 医療/バイオ

細胞凍結保存の世界市場2023-2032：機会分析・産業予測

◆英語タイトル：Cell Cryopreservation Market By Type (Cryopreservation media, Equipment), By Application (Stem cells, Oocytes cells, Sperm cells, Others), By End User (Pharmaceutical and biotechnology company, Research institute, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Allied Market Researchが発行した調査報告書（ALD23SEP160）◆商品コード：ALD23SEP160
◆発行会社（リサーチ会社）：Allied Market Research
◆発行日：2023年6月
◆ページ数：266
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：生命科学
◆販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

細胞凍結保存の市場規模は2022年に103億ドルと評価され、2023年から2032年までの年平均成長率は22.2%で、2032年には766億ドルに達すると予測されています。凍結保存とは、細胞小器官、細胞、組織、その他の生物学的構成要素を超低温（-80℃～-196℃）で凍結し、細胞代謝を停止させることにより、細胞を無期限に保存することです。低温では、生きている細胞の生物学的・化学的反応は劇的に低下します。そのため、凍結保存は細胞の完全性と機能性を維持する上で重要な役割を果たし、生物学研究のワークフローに適しています。細胞内の水分が凍結すると、氷の形成によって溶質のバランスが崩れ、細胞構造が損傷する可能性があります。したがって、適切な凍結保護剤と添加剤を含む凍結培地と技術を適切に使用することで、研究者は細胞培養のために細胞の解凍後の生存率を最大化することができます。
世界の細胞凍結保存市場の成長は、女性の不妊症の増加と卵子凍結サイクルの増加が主な要因です。The Society for Assisted Reproductive Technology（生殖補助技術協会）によると、米国では2020年から2021年にかけて卵子凍結サイクルが31%増加すると報告されています。バイオバンクは、生物医学研究、創薬、個別化医療を促進する上で重要な役割を担っているため、注目を集めています。バイオバンク・リソース・センターによると、2023年現在、カナダと国際的なバイオバンクを含めて340のバイオバンクが登録されています。

さらに、Journal of Biopreservation and Biobankingによると、2022年には、BBMRIのディレクトリに17カ国641のバイオバンクが登録されていると報告されています（2021年2月12日現在）。バイオバンキング技術の進歩や、より大規模で包括的なバイオバンクの設立に伴い、効率的で信頼性の高い細胞凍結保存法の需要は著しく高まっています。さらに、製薬業界やバイオテクノロジー業界における研究開発活動の増加、研究開発活動に対する政府支援の増加、癌やパーキンソン病などの慢性疾患の有病率の増加が市場の成長を後押ししています。

さらに、国立医学図書館によると、2022年には、網膜疾患、パーキンソン病、ハンチントン病、脊髄損傷、心筋梗塞、1型糖尿病などの幅広い疾患の治療のために、胚性幹細胞でさまざまな前臨床研究活動が行われていると報告されています。また、インド政府は、インド医学研究評議会（ICMR）、バイオテクノロジー省（DBT）、科学技術省（DST）などの国家助成機関を通じて、基礎研究や臨床研究を支援し、様々な省庁や機関を通じて幹細胞研究を実施しました。

さらに、Regulatory Affairs Professionals Societyによると、2021年には約2,754のクリニックが幹細胞治療を提供しています。その結果、幹細胞治療に対する需要の高まりが細胞凍結保存市場の重要な促進要因となっています。さらに、個別化医療に対する需要の急増は、細胞凍結保存市場の重要な促進要因として作用すると予想されます。免疫細胞ベースの免疫療法や人工細胞療法などの細胞ベースの療法は、個別化治療のアプローチとして研究されています。凍結保存は、個別化治療の開発に使用できる免疫細胞を含む患者固有の細胞の長期保存を可能にします。

これらの細胞を保存することで、凍結保存は患者特異的治療に必要な時に利用できるようにします。個別化医療への関心が高まるにつれ、細胞凍結保存法や保存施設に対する需要も同時に高まり、世界市場の成長を後押ししています。さらに、不妊率の上昇も市場の成長に大きく寄与しています。しかし、細胞凍結保存の代替療法が利用可能であることや、保存手順の維持コストが高いことが市場成長の妨げとなっています。
世界の細胞凍結保存市場は、タイプ、用途、エンドユーザー、地域に区分されます。タイプ別では、凍結保存培地と機器に二分されます。凍結保存培地セグメントはさらにエチレングリコール、ジメチルスルホキシド、グリセロール、その他に細分化されます。機器セグメントは冷凍庫、液体窒素供給タンク、その他にサブセグメント化されます。

用途別では、幹細胞、卵細胞、精子細胞、その他に分類されます。エンドユーザー別では、製薬・バイオ企業、研究機関、その他に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州）、アジア太平洋（中国、日本、オーストラリア、インド、その他アジア太平洋）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他LAMEA）に調査されています。 主要企業は、Merck Group KGaA, HiMedia Laboratories, Thermo Fisher Scientific Inc. , Eppendorf Corporate, BioLife Solutions, Inc., Lonza, Sartorius AG, Creative Biolabs, Sartorius AG, and PromoCell GmbH.などがあります。

ステークホルダーにとっての主なメリット
本レポートは、2021年から2031年までの細胞凍結保存市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、細胞凍結保存市場の有力な市場機会を特定します。
主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
細胞凍結保存市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
地域別および世界別の細胞凍結保存市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

主要市場セグメント
タイプ別
凍結保存培地
薬剤
エチレングリコール
ジメチルスルホキシド
グリセロール
その他
装置
種類
フリーザー
液体窒素供給タンク
その他

用途別
幹細胞
卵子細胞
精子細胞
その他

エンドユーザー別
製薬・バイオ企業
研究機関
その他

地域別
北米
米国
カナダ
メキシコ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
アジア太平洋
日本
中国
インド
オーストラリア
韓国
マレーシア
その他のアジア太平洋地域
LAMEA
ブラジル
南アフリカ
サウジアラビア
その他の地域

主要市場プレイヤー
○ BioLife Solutions, Inc.
○ Creative Biolabs
○ Danaher Corporation
○ Eppendorf Corporate
○ HiMedia Laboratories
○ Lonza
○ Merck Group KGaA
○ PromoCell GmbH
○ Sartorius AG
○ Thermo Fisher Scientific Inc. 

第1章：イントロダクション
第2章：エグゼクティブサマリー
第3章：市場概要
第4章：細胞凍結保存市場、タイプ別
第5章：細胞凍結保存市場、用途別
第6章：細胞凍結保存市場、エンドユーザー別
第7章：細胞凍結保存市場、地域別
第8章：競争状況
第9章：企業情報

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in number of egg freezing cycles
3.4.1.2. Increase in research and development activities for stem cells
3.4.1.3. Rise in number of biobanks and surge in demand for personalized medicines

3.4.2. Restraints
3.4.2.1. Availability of alternative therapies for cell cryopreservation

3.4.3. Opportunities
3.4.3.1. Increase in government support for research and development activities
3.4.3.2. Rise in focus of manufacturers on developing novel products for preserving various cells

3.5. COVID-19 Impact Analysis on the market
3.6. Patent Landscape
CHAPTER 4: CELL CRYOPRESERVATION MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Cryopreservation media
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Cryopreservation media Cell Cryopreservation Market by Agent
4.3. Equipment
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Equipment Cell Cryopreservation Market by Type
CHAPTER 5: CELL CRYOPRESERVATION MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Stem cells
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Oocytes cells
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Sperm cells
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: CELL CRYOPRESERVATION MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Pharmaceutical and biotechnology company
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Research institute
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: CELL CRYOPRESERVATION MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Malaysia
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End User
7.4.5.7. Rest of Asia-Pacific
7.4.5.7.1. Key market trends, growth factors and opportunities
7.4.5.7.2. Market size and forecast, by Type
7.4.5.7.3. Market size and forecast, by Application
7.4.5.7.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. South Africa,
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. Saudi Arabia
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Creative Biolabs
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. Eppendorf Corporate
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Lonza
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. PromoCell GmbH
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Sartorius AG
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. BioLife Solutions, Inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Danaher Corporation
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Thermo Fisher Scientific Inc. 
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. HiMedia Laboratories
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Merck Group KGaA
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance

LIST OF TABLES
TABLE 01. GLOBAL CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. CELL CRYOPRESERVATION MARKET FOR CRYOPRESERVATION MEDIA, BY REGION, 2022-2032 ($MILLION)
TABLE 03. GLOBAL CRYOPRESERVATION MEDIA CELL CRYOPRESERVATION MARKET, BY AGENT, 2022-2032 ($MILLION)
TABLE 04. CELL CRYOPRESERVATION MARKET FOR EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL EQUIPMENT CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 06. GLOBAL CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 07. CELL CRYOPRESERVATION MARKET FOR STEM CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. CELL CRYOPRESERVATION MARKET FOR OOCYTES CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. CELL CRYOPRESERVATION MARKET FOR SPERM CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. CELL CRYOPRESERVATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 12. CELL CRYOPRESERVATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY, BY REGION, 2022-2032 ($MILLION)
TABLE 13. CELL CRYOPRESERVATION MARKET FOR RESEARCH INSTITUTE, BY REGION, 2022-2032 ($MILLION)
TABLE 14. CELL CRYOPRESERVATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. CELL CRYOPRESERVATION MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 21. U.S. CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 22. U.S. CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. CANADA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 24. CANADA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. CANADA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. MEXICO CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 27. MEXICO CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. MEXICO CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 30. EUROPE CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 31. EUROPE CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. EUROPE CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 34. GERMANY CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. GERMANY CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. FRANCE CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 37. FRANCE CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 38. FRANCE CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. UK CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. UK CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. UK CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. ITALY CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 43. ITALY CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 44. ITALY CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. SPAIN CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 46. SPAIN CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. SPAIN CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 56. JAPAN CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 57. JAPAN CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. CHINA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 59. CHINA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. CHINA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. INDIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 62. INDIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 63. INDIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 65. AUSTRALIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. AUSTRALIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. MALAYSIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 71. MALAYSIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 72. MALAYSIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 75. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 76. LAMEA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 77. LAMEA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 78. LAMEA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 79. LAMEA CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 80. BRAZIL CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 81. BRAZIL CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 82. BRAZIL CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 87. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 88. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. REST OF LAMEA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 90. REST OF LAMEA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 91. REST OF LAMEA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 92. CREATIVE BIOLABS: KEY EXECUTIVES
TABLE 93. CREATIVE BIOLABS: COMPANY SNAPSHOT
TABLE 94. CREATIVE BIOLABS: PRODUCT SEGMENTS
TABLE 95. CREATIVE BIOLABS: SERVICE SEGMENTS
TABLE 96. CREATIVE BIOLABS: PRODUCT PORTFOLIO
TABLE 97. EPPENDORF CORPORATE: KEY EXECUTIVES
TABLE 98. EPPENDORF CORPORATE: COMPANY SNAPSHOT
TABLE 99. EPPENDORF CORPORATE: PRODUCT SEGMENTS
TABLE 100. EPPENDORF CORPORATE: PRODUCT PORTFOLIO
TABLE 101. EPPENDORF CORPORATE: KEY STRATERGIES
TABLE 102. LONZA: KEY EXECUTIVES
TABLE 103. LONZA: COMPANY SNAPSHOT
TABLE 104. LONZA: PRODUCT SEGMENTS
TABLE 105. LONZA: SERVICE SEGMENTS
TABLE 106. LONZA: PRODUCT PORTFOLIO
TABLE 107. PROMOCELL GMBH: KEY EXECUTIVES
TABLE 108. PROMOCELL GMBH: COMPANY SNAPSHOT
TABLE 109. PROMOCELL GMBH: PRODUCT SEGMENTS
TABLE 110. PROMOCELL GMBH: PRODUCT PORTFOLIO
TABLE 111. SARTORIUS AG: KEY EXECUTIVES
TABLE 112. SARTORIUS AG: COMPANY SNAPSHOT
TABLE 113. SARTORIUS AG: PRODUCT SEGMENTS
TABLE 114. SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 115. BIOLIFE SOLUTIONS, INC.: KEY EXECUTIVES
TABLE 116. BIOLIFE SOLUTIONS, INC.: COMPANY SNAPSHOT
TABLE 117. BIOLIFE SOLUTIONS, INC.: PRODUCT SEGMENTS
TABLE 118. BIOLIFE SOLUTIONS, INC.: SERVICE SEGMENTS
TABLE 119. BIOLIFE SOLUTIONS, INC.: PRODUCT PORTFOLIO
TABLE 120. BIOLIFE SOLUTIONS, INC.: KEY STRATERGIES
TABLE 121. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 122. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 123. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 124. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 125. DANAHER CORPORATION: KEY STRATERGIES
TABLE 126. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
TABLE 127. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
TABLE 128. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
TABLE 129. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
TABLE 130. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
TABLE 131. THERMO FISHER SCIENTIFIC INC. : KEY STRATERGIES
TABLE 132. HIMEDIA LABORATORIES: KEY EXECUTIVES
TABLE 133. HIMEDIA LABORATORIES: COMPANY SNAPSHOT
TABLE 134. HIMEDIA LABORATORIES: PRODUCT SEGMENTS
TABLE 135. HIMEDIA LABORATORIES: PRODUCT PORTFOLIO
TABLE 136. MERCK GROUP KGAA: KEY EXECUTIVES
TABLE 137. MERCK GROUP KGAA: COMPANY SNAPSHOT
TABLE 138. MERCK GROUP KGAA: PRODUCT SEGMENTS
TABLE 139. MERCK GROUP KGAA: PRODUCT PORTFOLIO

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 細胞凍結保存の世界市場2023-2032：機会分析・産業予測(Cell Cryopreservation Market By Type (Cryopreservation media, Equipment), By Application (Stem cells, Oocytes cells, Sperm cells, Others), By End User (Pharmaceutical and biotechnology company, Research institute, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • いびき防止装置の世界市場2023-2032：機会分析・産業予測
  • ニュートリゲノミクスの世界市場2023-2032：機会分析・産業予測
  • 心臓パッチモニターーの世界市場2023-2032：機会分析・産業予測
  • CAR-T細胞療法の世界市場2023-2032：機会分析・産業予測
  • 歯内療法用ファイルの世界市場2023-2032：機会分析・産業予測

    • ◆H&Iグローバルリサーチのお客様（例）◆